<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04486040</url>
  </required_header>
  <id_info>
    <org_study_id>GrucaTH</org_study_id>
    <nct_id>NCT04486040</nct_id>
  </id_info>
  <brief_title>Closed Suction Drainage After Revision Hip Arthroplasty</brief_title>
  <official_title>Closed Suction Drainage After Revision Hip Arthroplasty - Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof A Gruca Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prof A Gruca Teaching Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized trial. 38 patients who underwent revision hip arthroplasty, divided
      in to two groups with or without drainage. All patients was assessed with ultrasonography on
      3rd day after surgery. Bleeding, need for blood transfusion and laboratory test was analyzed
      after surgery. Patients was assessed with Harris Hips Score and Visual Analog Scale after
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria: aseptic loosening, head or insert damage, girdlestone hip. Exclusion
      criteria: septic loosening, primary or secondary coagulopathy, renal or hepatic failure,
      thromboembolism in past history. At the end of operation information of drainage was get out
      from the envelope. On 3rd day all patient get ultrasonography with level of fluid in the
      joint and hematoma in soft tissue measurement. We analyzed hemoglobin, C-reactive protein,
      erythrocyte sedimentation rate on 1st and 3rd day after surgery. Visual analog scale was
      taken on 3rd day after surgery and Harris Hip Score 6 weeks after.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 14, 2016</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hematoma size</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Level of fluid at endoprosthesis neck in ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin level</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Hemoglobin level after surgery on 1st and 3rd day after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day after surgery</time_frame>
    <description>Assessing blood loss with use of Gross formula</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reinfection</measure>
    <time_frame>2 years after surgery</time_frame>
    <description>Number of patients with infection after surgery performed in the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Soft tissue hematoma</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Note hematoma formation in soft tissue after surgery (ultrasonography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein level</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Level of C-reactive protein after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusion</measure>
    <time_frame>5-14 days after surgery</time_frame>
    <description>Number of patients who need blood transfusion after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Level of pain after surgery, 1- no pain; 10- &quot;the worst pain you ever had&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>6 weeks after surgery</time_frame>
    <description>Clinical outcome after surgery, 0-100 points; 100 points the best score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Drainage group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with drainage after hip revision arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No-drainage group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients without drainage after hip revision arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Drainage</intervention_name>
    <description>Use of the suction drainage after hip revision arthroplasty</description>
    <arm_group_label>Drainage group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No-drainage</intervention_name>
    <description>Patients without drainage after surgery</description>
    <arm_group_label>No-drainage group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aseptic loosening,

          -  head or insert damage,

          -  girdlestone hip

        Exclusion Criteria:

          -  septic loosening,

          -  primary or secondary coagulopathy,

          -  renal or hepatic failure,

          -  thromboembolism in past history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pawel Bartosz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gruca Teaching Hospital, Centre of Postgraduate Medical Education in Otwock</affiliation>
  </overall_official>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 22, 2020</study_first_submitted>
  <study_first_submitted_qc>July 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Prof A Gruca Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Bartosz Pawe≈Ç</investigator_full_name>
    <investigator_title>M.D., Ph.D. Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>Revision</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

